Biotechnology
PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC
DAEJEON, South Korea, Aug. 3, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to evaluate the combination of each party's clinical candidate, olinvacimab and C-005, a3rd generation of EGFR inhibitor with s...
2020-08-03 21:00
2066
GranBio and NextChem sign partnership to develop cellulosic ethanol market
SAO PAULO and ROME, Aug. 3, 2020 /PRNewswire/ -- GranBio, a 100% Brazilian industrial biotechnology company, and NextChem, Maire Tecnimont's subsidiary for energy transition announced a strategic partnership to achieve global leadership in the licensing of patented GranBio 2G Ethanol technology t...
2020-08-03 20:54
3570
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
SUZHOU, China, Aug. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
2020-08-03 08:00
9061
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
- INO-4800 showed durable antibody and T cell responses in rhesus macaques for 4 months - INO-4800 is the only vaccine to demonstrate long-term protection in non-human primates challenged with SARS-CoV-2 virus 13 weeks from vaccination - Memory T and B cell responses resulted in reduced viral l...
2020-07-30 20:34
6065
Seegene Allplex(TM) 2019-nCoV Assay (SARS-CoV-2) Gets Expanded FDA Emergency Use Authorization
SEOUL, South Korea, July 30, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) has further expanded the emergency use authorization (EUA) for its Allplex™ 2019-nCoV Assay, a real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COV...
2020-07-30 19:00
2815
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that protects against subsequent infection First-in-human Phase 1/2a clinical trial now underway in United States and Belgium; Phase 3 clinical trial expected to commence in September NEW BR...
2020-07-30 17:55
10445
Global X China Biotech ETF and Global X China Cloud Computing ETF Named the Most Innovative ETFs in Hong Kong by The Asset
HONG KONG, July 30, 2020 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited ("Mirae Asset") is delighted that two of its Hong Kong-listed exchange-traded funds (ETF), theGlobal X China Biotech ETF (2820.HK) and Global X China Cloud Computing ETF (2826.HK), have been recognized as ...
2020-07-30 17:15
4496
Henlius and Accord Healthcare Receive EMA Approval for Zercepac®, trastuzumab biosimilar
SHANGHAI, July 30, 2020 /PRNewswire/ -- The European Commission (EC) has approved Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord)'s Zercepac®, a biosimilar trastuzumab, for the treatment of certain patients with HER2-positive early breast cancer, HER2-positive meta...
2020-07-30 08:00
5552
Global Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 30, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...
2020-07-30 04:16
18152
First successful trans-femoral mitral valve repair device DragonFly™ performed in China
HANGZHOU, China, July 29, 2020 /PRNewswire/ -- On July 23, 2020, Professor Jian'an Wang's team at the Second Affiliated Hospital of Zhejiang University School of Medicine successfully completed the world's first human clinical application of the transcatheter mitral valve repair system (Dragon...
2020-07-29 23:00
2571
SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity
BURLINGTON, Mass., July 29, 2020 /PRNewswire/ -- Sekisui announces the decision to invest £14.4 Million in its biopharma CDMO business aimed atcGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022. This investment follows the investme...
2020-07-29 21:00
3619
INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)
PLYMOUTH MEETING, Pennsylvania, July 29, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for INO-3107, its DNA medicine being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomat...
2020-07-29 19:30
4679
BIO Asia-Taiwan 2020 Concludes Successfully
TAIPEI, July 29, 2020 /PRNewswire/ -- BIO Asia-Taiwan 2020 International Conference and Exhibition, the world's first combined onsite plus online biotechnology conference, closed onJuly 26. Held in Taipei, from July 22 to 26, the event attracted over 5,000 viewers to its online conference, of whi...
2020-07-29 17:35
2951
Celltrion Selects Movilitas for Serialization and Traceability Implementations to Ensure Supply Chain Integrity and Compliance
Project delivers a combined solution for end-to-end visibility in EU, Korea and U.S. markets COLUMBIA, Maryland, July 29, 2020 /PRNewswire/ -- Movilitas, a technology leader delivering the next generation of solutions and consulting services across multiple industries to advance smart supply cha...
2020-07-29 09:38
2750
Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets
SHANGHAI and NEWYORK, July 28, 2020 /PRNewswire/ -- Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generatingde novo crystal structures of high-value targets. Under the terms ...
2020-07-29 07:00
11133
Oscotec to Use CDD Vault to Manage Its Chemistry and Biological Research Data
The company selected the platform to help streamline its drug discovery data management process SEONGNAM-SI, South Korea and BURLINGAME, California, July 29, 2020 /PRNewswire/ -- Oscotec, a Korean biotech company engaged in the clinical stage discovery of novel drug candidates for unmet needs, a...
2020-07-29 07:00
5143
Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited
BENGALURU, India, July 28, 2020 /PRNewswire/ -- Jubilant Biosys Limited ("Biosys"), a wholly owned subsidiary of Jubilant Life Sciences Limited, today announced completion of the merger with its sister company Jubilant Chemsys Limited, based in Noida,India. The combined entities will now operate ...
2020-07-28 20:27
4876
"White Mouse in Water" - Infinitus Develops New Technology of Using Zebrafish for Health Products Screening
GUANGZHOU, China, July 28, 2020 /PRNewswire/ -- Recently, the Chinese Institute of Food Science and Technology (CIFST) brought together experts inBeijing to evaluate the results of a collaborative R&D effort between Infinitus (China) Company Ltd. and Hangzhou Hunter Biotechnology Co., Ltd., named...
2020-07-28 20:00
4645
Chengdu Hi-tech Zone Made an Increase by 7% in Industrial Added Value in the First Half of the Year
CHENGDU, China, July 28, 2020 /PRNewswire/ -- In the first half of the year,
Chengdu Hi-tech Zone harvested a fruitful reward in industrial added value worth
RMB119.14 billion, with a year-on-year increase of 7.0%.
2020-07-28 16:35
4928
Sherpa Healthcare Partners Announces Close of Oversubscribed Fund
BEIJING, July 27, 2020 /PRNewswire/ -- Sherpa Healthcare Partners is pleased to announce the final closing of the oversubscribed Sherpa Healthcare Fund I, L.P. The fund focuses on early- to growth-stage investment in the healthcare sector to cover companies in biotech, biopharma, medical devices ...
2020-07-28 11:33
2458
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5203
